Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease
- 31 March 2005
- journal article
- review article
- Published by Elsevier in Neurobiology of Aging
- Vol. 26 (3) , 355-361
- https://doi.org/10.1016/j.neurobiolaging.2004.09.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-β (Aβ) 40 or Aβ 42 in humansNeuroscience Letters, 2003
- Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptideNeurology, 2002
- Statins and the risk of dementiaThe Lancet, 2000
- Apolipoprotein E receptors: linking brain development and alzheimer's diseaseNature Reviews Neuroscience, 2000
- Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependentBrain Research, 1999
- Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's diseaseJournal of Clinical Investigation, 1999
- Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injuryNeurology, 1999
- The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's diseaseBrain Research Reviews, 1998
- Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein ε4 AlleleJournal of Neuroscience, 1997
- A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.Journal of Clinical Investigation, 1989